Misoprostol
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | CYTOTEC | — | 1988-12-27 | fda.gov ↗ |
Trials 220 · started per year
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 05 trials · 1 met primary | ||||||
| Phase 0 | NCT06874049 | Feb → Aug 2025 overdue | — | Hagar Muhammad Abdulfattah Muhammad | Active not recruiting | No outcome recorded |
| Phase 0 | NCT06199154 | Jul 2024 → May 2026 overdue | morbid obesity, pregnancy disorder | University of Maryland, Baltimore | Recruiting | No outcome recorded |
| Phase 0 | NCT04768010 | Aug → Sep 2023 | constipation disorder, gas bloat syndrome | Montefiore Medical Center | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 0 | NCT02424201 | Jun → Dec 2015 | pregnancy disorder | Lagos State University | Unknown | Met primary |
| Phase 0 | NCT02259309 | Nov 2014 → Jul 2015 | — | Vanderbilt University | Completed | No outcome recorded |
| Phase 17 trials · 1 met primary | ||||||
| Phase 1 | NCT07526064 | May → Jul 2026 overdue | pregnancy disorder with abortive outcome | Hamna Khaliq | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT06502158 | Oct 2024 → Oct 2026 expected | — | Montefiore Medical Center | Recruiting | No outcome recorded |
| Phase 1 | NCT06364098 | Jan 2022 → Feb 2023 | — | Cairo University | Completed | Met primary |
| Phase 1 | NCT01863706 | May → Dec 2013 | — | Hormozgan University of Medical Sciences | Completed | No outcome recorded |
| Phase 1 | NCT01271257 | Jan 2011 → Dec 2014 | — | China Medical University Hospital | Completed | No outcome recorded |
| Phase 1 | NCT00592215 | Mar 2008 → Apr 2010 | — | Johns Hopkins University | Withdrawn | No outcome recorded |
| Phase 1 | NCT00906126 | Apr 2007 → Sep 2008 | dystocia | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00432588 | — | preeclampsia, preterm premature rupture of the membranes | Hormozgan University of Medical Sciences | Unknown | No outcome recorded |
| Phase 226 trials · 1 missed | ||||||
| Phase 2 | NCT06452719 | Aug 2024 → Jul 2026 overdue | pregnancy disorder with abortive outcome, pregnancy loss, recurrent, 4 | University of Pennsylvania | Recruiting | No outcome recorded |
| Phase 2 | NCT05216952 | May 2022 → Jan 2023 | pregnancy disorder with abortive outcome | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 2 | NCT05207644 | Dec 2021 → Apr 2022 | pregnancy disorder | Gynuity Health Projects | Completed | No outcome recorded |
| Phase 2 | NCT04724187 | Feb → Aug 2021 | — | Islamabad Medical and Dental College | Unknown | No outcome recorded |
| Phase 2 | NCT04604366 | Nov 2020 → Dec 2021 | pregnancy disorder with abortive outcome | Islamabad Medical and Dental College | Completed | No outcome recorded |
| Phase 2 | NCT03972358 | Feb 2020 → Dec 2021 | menstrual disorder | Gynuity Health Projects | Unknown | No outcome recorded |
| Phase 2 | NCT03927807 | Mar → Dec 2019 | — | Ain Shams University | Unknown | No outcome recorded |
| Phase 2 | NCT03617172 | Nov 2018 → Sep 2021 | Clostridium difficile colitis | Vanderbilt University Medical Center | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT03939663 | Jul 2018 → Jul 2019 | — | Ain Shams University | Unknown | No outcome recorded |
| Phase 2 | NCT02685085 | Feb → Aug 2016 | — | Woman's Health University Hospital, Egypt | Unknown | No outcome recorded |
| Phase 2 | NCT02989324 | Jan 2016 → Nov 2017 | — | Zagazig University | Completed | No outcome recorded |
| Phase 2 | NCT02409407 | Apr 2015 → Apr 2016 | infertility disorder | Kasr El Aini Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT02316301 | Jan → Dec 2015 | — | Cairo University | Completed | Mixed |
| Phase 2 | NCT01866488 | Apr 2013 → Oct 2016 | — | University of Arizona | Unknown | No outcome recorded |
| Phase 2 | NCT01765881 | Sep 2012 → Sep 2015 | uterine disorder | University Hospital, Toulouse | Completed | No outcome recorded |
| Phase 2 | NCT01283022 | May → Jul 2011 | cervix disorder | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 2 | NCT01134926 | Jun 2010 → May 2012 | uterine disorder | HaEmek Medical Center, Israel | Terminated | No outcome recorded |
| Phase 2 | NCT00925938 | Jan → Nov 2010 | cervix disorder | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 2 | NCT00828711 | Apr → Dec 2009 | cervix disorder | Ferring Pharmaceuticals | Completed | Missed primary |
| Phase 2 | NCT00330993 | Mar → Aug 2006 | — | University of Pittsburgh | Completed | No outcome recorded |
| Phase 2 | NCT00325026 | Apr 2005 → Apr 2007 | cervix disorder | University of Florida | Completed | No outcome recorded |
| Phase 2 | NCT00393731 | Jan 2004 → Aug 2007 | — | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
| Phase 2 | NCT00346840 | Jun 2003 → Feb 2004 | cervix disorder | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 2 | NCT00310921 | May 2001 → May 2006 | — | Kaiser Permanente | Completed | No outcome recorded |
| Phase 2 | NCT00107874 | Jan 1999 → Feb 2002 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| Phase 2 | NCT00528255 | — | cervix disorder | Ferring Pharmaceuticals | Withdrawn | No outcome recorded |
| Phase 2/311 trials · 2 met primary | ||||||
| Phase 2/3 | NCT07576881 | Jun 2026 → Dec 2027 expected | pregnancy disorder | Indiana University | Not yet recruiting | No outcome recorded |
| Phase 2/3 | NCT05957666 | Jun → Dec 2023 | — | Services Institute of Medical Sciences, Pakistan | Unknown | No outcome recorded |
| Phase 2/3 | NCT02901561 | Sep → Dec 2016 | — | Assiut University | Completed | No outcome recorded |
| Phase 2/3 | NCT04270994 | Sep 2016 → Aug 2019 | endometrial polyp | Henry Aristoteles Mate-Sánez | Completed | No outcome recorded |
| Phase 2/3 | NCT02509351 | Oct 2015 → Nov 2016 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 2/3 | NCT02299401 | Dec 2014 → Oct 2016 | pregnancy disorder | Gynuity Health Projects | Completed | Met primary |
| Phase 2/3 | NCT02141321 | May 2014 → Jan 2015 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 2/3 | NCT02083107 | Feb 2013 → Feb 2014 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 2/3 | NCT01477840 | Aug 2012 | — | Soudabeh Eshghi ali | Unknown | Met primary |
| Phase 2/3 | NCT01615224 | May 2012 → Oct 2019 | pregnancy disorder with abortive outcome | Kristina Gemzell Danielsson | Terminated | No outcome recorded Stop: Business |
| Phase 2/3 | NCT00148473 | Mar 2000 → Oct 2001 | hypertension, pregnancy-induced | Bangkok Metropolitan Administration Medical College and Vajira Hospital | Completed | No outcome recorded |
| Phase 339 trials · 3 met primary · 2 missed | ||||||
| Phase 3 | NCT07506512 | Jul 2027 → Jul 2031 expected | pregnancy loss, recurrent, 4 | University of Pennsylvania | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT05245227 | Jan 2025 → Jan 2027 expected | — | Stony Brook University | Recruiting | No outcome recorded |
| Phase 3 | NCT06078501 | Feb → Jul 2024 | — | Stanford University | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT05839899 | Aug 2023 → Jul 2024 | — | Planned Parenthood League of Massachusetts | Unknown | No outcome recorded |
| Phase 3 | NCT05424445 | Jan → Dec 2022 | — | Karolinska Institutet | Completed | No outcome recorded |
| Phase 3 | NCT04635007 | Jan 2021 → Jun 2022 | — | Cairo University | Completed | No outcome recorded |
| Phase 3 | NCT04560218 | Oct 2020 → Jul 2021 | — | Department of Medical Services Ministry of Public Health of Thailand | Completed | No outcome recorded |
| Phase 3 | NCT04339348 | Apr 2020 → Feb 2021 | — | Cairo University | Completed | No outcome recorded |
| Phase 3 | NCT04152317 | Nov 2019 → Sep 2020 | cervix disorder | Professor Fernando Figueira Integral Medicine Institute | Completed | Missed primary |
| Phase 3 | NCT05108597 | Mar 2019 → Mar 2020 | leiomyoma | Pak Emirates Military Hospital | Completed | No outcome recorded |
| Phase 3 | NCT05761418 | Mar 2018 → Feb 2023 | leiomyoma | Beni-Suef University | Completed | No outcome recorded |
| Phase 3 | NCT03483142 | Nov 2017 → Jul 2018 | leiomyoma | ahmed nagy shaker ramadan | Unknown | No outcome recorded |
| Phase 3 | NCT03148574 | Jul 2017 → Sep 2019 | — | Assiut University | Completed | No outcome recorded |
| Phase 3 | NCT03269279 | May 2017 → Dec 2019 | — | Gynuity Health Projects | Unknown | No outcome recorded |
| Phase 3 | NCT02985229 | Oct 2016 → Jul 2017 | — | Gynuity Health Projects | Completed | No outcome recorded |
| Phase 3 | NCT02758340 | Apr → Nov 2016 | — | Karachi Medical and Dental College | Completed | No outcome recorded |
| Phase 3 | NCT02686840 | Jan 2016 → Jan 2017 | pregnancy disorder with abortive outcome | Ain Shams University | Completed | Met primary |
| Phase 3 | NCT02163616 | Sep 2015 → May 2016 | — | Gynuity Health Projects | Completed | No outcome recorded |
| Phase 3 | NCT02265562 | Oct 2014 → May 2015 | — | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT02036437 | Sep 2013 → Sep 2014 | indomethacin embryofetopathy | Ain Shams University | Unknown | No outcome recorded |
| Phase 3 | NCT01710566 | Jul 2013 → Dec 2014 | — | Gynuity Health Projects | Withdrawn | No outcome recorded |
| Phase 3 | NCT02061657 | Jun 2013 → Jun 2014 | leiomyoma | Ain Shams University | Completed | Met primary |
| Phase 3 | NCT01795599 | May 2013 → Feb 2015 | — | Assistance Publique Hopitaux De Marseille | Unknown | No outcome recorded |
| Phase 3 | NCT01805115 | Mar 2013 → Jan 2014 | endometrial disorder | CHA University | Completed | Met primary |
| Phase 3 | NCT01866241 | Nov 2012 → Sep 2013 | — | Mbarara University of Science and Technology | Completed | Missed primary |
| Phase 3 | NCT01428037 | Mar 2012 → Jan 2013 | cervix disorder | Regenex Pharmaceutical, China | Completed | No outcome recorded |
| Phase 3 | NCT01127581 | Sep 2010 → Mar 2012 | cervix disorder | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT00920465 | Jun 2009 → Dec 2011 | — | Western Galilee Hospital-Nahariya | Unknown | No outcome recorded |
| Phase 3 | NCT01024270 | Jul 2008 → Jul 2009 | — | Samsung Medical Center | Completed | No outcome recorded |
| Phase 3 | NCT01156948 | May 2008 → Aug 2010 | cervix disorder | Wenzhou Medical University | Unknown | No outcome recorded |
| Phase 3 | NCT01373359 | Mar 2007 → Jan 2008 | — | Jawaharlal Nehru Medical College | Completed | No outcome recorded |
| Phase 3 | NCT00363389 | Sep 2006 → May 2007 | uterine disorder | Ullevaal University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT00308711 | Apr 2006 → Aug 2007 | cervix disorder | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT00529295 | Jun 2005 → Mar 2007 | — | China Medical University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT00602095 | Dec 2004 → Mar 2007 | pregnancy disorder | Karolinska University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT01116050 | Jan 2004 → Dec 2007 | — | University Hospital, Caen | Completed | No outcome recorded |
| Phase 3 | NCT00140114 | Jan 2004 → Sep 2006 | — | American University of Beirut Medical Center | Completed | No outcome recorded |
| Phase 3 | NCT00299754 | Jan 2003 → Dec 2004 | — | KK Women's and Children's Hospital | Completed | No outcome recorded |
| Phase 3 | NCT03489928 | Apr 1999 → Dec 2000 | — | David Young | Completed | No outcome recorded |
| Phase 454 trials · 4 met primary · 8 missed | ||||||
| Phase 4 | NCT07671989 | Jun → Dec 2026 expected | menstrual disorder | University of California, San Francisco | Recruiting | No outcome recorded |
| Phase 4 | NCT07286188 | Dec 2025 → Dec 2026 expected | leiomyoma | Northwestern University | Recruiting | No outcome recorded |
| Phase 4 | NCT07174856 | Oct 2025 → Jan 2027 expected | — | Ibis Reproductive Health | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06049745 | Nov 2023 → Aug 2026 overdue | submucous uterine fibroid | Assuta Ashdod Hospital | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT05119439 | Oct 2022 → Jun 2023 | — | Gynuity Health Projects | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT05262738 | Jun 2022 → Jul 2023 | obesity disorder, pregnancy disorder | University of Texas at Austin | Completed | Missed primary |
| Phase 4 | NCT05124314 | Oct 2021 → Oct 2023 | — | Clinical Hospital Merkur | Unknown | No outcome recorded |
| Phase 4 | NCT04940013 | Oct 2021 → Sep 2025 | menstrual disorder | University of California, San Francisco | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT05046041 | Nov 2020 → Aug 2021 | — | Gynuity Health Projects | Completed | No outcome recorded |
| Phase 4 | NCT03749902 | Jan 2020 → Jul 2022 | — | University of Liverpool | Completed | No outcome recorded |
| Phase 4 | NCT04685694 | Jan 2020 → Dec 2021 | — | Tel-Aviv Sourasky Medical Center | Completed | Missed primary |
| Phase 4 | NCT03829696 | Jan 2020 → Jan 2021 | — | University of California, San Francisco | Withdrawn | No outcome recorded |
| Phase 4 | NCT04063904 | Oct 2019 → Apr 2020 | — | Gynuity Health Projects | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT03670836 | Nov 2018 → Jul 2021 | — | Columbia University | Completed | Met primary |
| Phase 4 | NCT03676621 | Nov 2018 → Aug 2021 | — | Assiut University | Completed | No outcome recorded |
| Phase 4 | NCT03682718 | Oct 2018 → Jan 2019 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT03547778 | Sep 2018 → Dec 2019 | — | University of South Florida | Withdrawn | No outcome recorded |
| Phase 4 | NCT03591913 | Feb → Aug 2018 | — | Assiut University | Completed | No outcome recorded |
| Phase 4 | NCT03346629 | Dec 2017 → Dec 2018 | — | Gynuity Health Projects | Completed | No outcome recorded |
| Phase 4 | NCT02777190 | Nov 2017 → Apr 2019 | pregnancy disorder | Milton S. Hershey Medical Center | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT03815344 | Apr 2017 → Jun 2019 | leiomyoma | Antonios Likourezos | Completed | No outcome recorded |
| Phase 4 | NCT02716142 | Mar 2017 → Dec 2019 | — | Assiut University | Completed | No outcome recorded |
| Phase 4 | NCT02981030 | Nov 2016 → Jun 2017 | — | Gynuity Health Projects | Completed | No outcome recorded |
| Phase 4 | NCT03134183 | Nov 2016 → Aug 2017 | — | Virginia Commonwealth University | Completed | No outcome recorded |
| Phase 4 | NCT03064568 | Oct 2016 → Jun 2024 | — | The University of Texas Health Science Center at San Antonio | Completed | No outcome recorded |
| Phase 4 | NCT02853552 | Oct 2016 → Oct 2017 | — | Gynuity Health Projects | Unknown | No outcome recorded |
| Phase 4 | NCT02908295 | Sep 2016 → Dec 2017 | — | Department of Medical Services Ministry of Public Health of Thailand | Completed | No outcome recorded |
| Phase 4 | NCT02745093 | Sep → Dec 2016 | — | Ibis Reproductive Health | Unknown | No outcome recorded |
| Phase 4 | NCT02918110 | Sep 2016 → Sep 2017 | — | Karolinska Institutet | Unknown | Missed primary |
| Phase 4 | NCT02704481 | Jun 2016 → Jan 2019 | — | Gynuity Health Projects | Terminated | No outcome recorded Stop: Business |
| Phase 4 | NCT02762942 | May 2016 → May 2017 | cervix disorder, pregnancy disorder | Consorci Sanitari de Terrassa | Unknown | No outcome recorded |
| Phase 4 | NCT02314754 | Dec 2014 → Apr 2016 | — | Gynuity Health Projects | Completed | No outcome recorded |
| Phase 4 | NCT02732522 | Oct 2014 → May 2015 | cervix disorder | University of the Republic | Completed | Missed primary |
| Phase 4 | NCT02226588 | Oct 2014 → Jan 2016 | — | Gynuity Health Projects | Completed | No outcome recorded |
| Phase 4 | NCT02209545 | Oct 2014 → Jul 2022 | leiomyoma | Northwestern University | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT02720991 | Jul 2014 → Apr 2015 | — | Gynuity Health Projects | Completed | No outcome recorded |
| Phase 4 | NCT01856985 | Apr → Sep 2013 | — | Gynuity Health Projects | Completed | No outcome recorded |
| Phase 4 | NCT01798017 | Nov 2012 → Jun 2015 | menstrual disorder | Gynuity Health Projects | Completed | No outcome recorded |
| Phase 4 | NCT01620814 | Jul → Aug 2012 | cervix disorder | Zekai Tahir Burak Women's Health Research and Education Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT01519765 | Jul 2011 → Dec 2014 | pregnancy disorder | University of California, Los Angeles | Terminated | Missed primary Stop: Enrollment |
| Phase 4 | NCT01549223 | Apr 2011 → Jan 2012 | hypotensive disorder, uterine disorder | Brigham and Women's Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01113229 | Mar 2010 → Jul 2014 | obstetric disorder | Assistance Publique - Hôpitaux de Paris | Terminated | Missed primary |
| Phase 4 | NCT00997347 | Jul 2009 → Feb 2012 | — | Gynuity Health Projects | Completed | No outcome recorded |
| Phase 4 | NCT00886860 | May → Dec 2009 | cervix disorder | Mahidol University | Completed | Missed primary |
| Phase 4 | NCT01387256 | May 2009 → Jul 2010 | — | Gynuity Health Projects | Completed | No outcome recorded |
| Phase 4 | NCT01733329 | Feb 2008 → Dec 2013 | — | Hospital Universitario Dr. Jose E. Gonzalez | Completed | Met primary |
| Phase 4 | NCT01231126 | Feb 2008 → Jan 2009 | pregnancy disorder | Maternidade Escola Assis Chateaubriand | Completed | No outcome recorded |
| Phase 4 | NCT00695331 | Feb → Dec 2008 | — | China Medical University Hospital | Unknown | Missed primary |
| Phase 4 | NCT00129506 | May → Sep 2005 | — | Wiebe, Ellen, M.D. | Completed | No outcome recorded |
| Phase 4 | NCT01700478 | Feb → Apr 2005 | hemorrhagic disease | University Hospital of the West Indies | Completed | Met primary |
| Phase 4 | NCT00177372 | Jan → Sep 2005 | pregnancy disorder with abortive outcome | University of Pittsburgh | Completed | No outcome recorded |
| Phase 4 | NCT00269568 | Jun 2004 → Apr 2006 | — | University of Pittsburgh | Completed | Met primary |
| Phase 4 | NCT00190294 | Apr 2003 → Sep 2006 | pregnancy disorder | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 4 | NCT00256009 | ? → Jan 2009 | habitual spontaneous abortion | Rigshospitalet, Denmark | Unknown | No outcome recorded |
| Phase not applicable77 trials · 11 met primary · 7 missed | ||||||
| — | NCT07697781 | Jan → Jul 2026 overdue | endometrial disorder | Faculty of Medicine of Tunis | Recruiting | No outcome recorded |
| — | NCT07559812 | Oct 2025 → Apr 2026 overdue | cervix disorder, pregnancy disorder | Mayo Hospital Lahore | Active not recruiting | No outcome recorded |
| — | NCT06669533 | Feb 2025 → Nov 2027 expected | cervical cancer | University of Alabama at Birmingham | Recruiting | No outcome recorded |
| — | NCT06850974 | Feb 2025 → Mar 2027 expected | — | Stony Brook University | Recruiting | No outcome recorded |
| — | NCT07416487 | Feb → Dec 2025 | — | Muhammad Aamir Latif | Completed | No outcome recorded |
| — | NCT07534982 | Jul 2024 → Jul 2027 expected | — | Yael Yagur | Recruiting | No outcome recorded |
| — | NCT07121634 | Jan 2024 → Aug 2025 overdue | cervix disorder | Raid M. Al-Ani | Active not recruiting | No outcome recorded |
| — | NCT06060327 | Oct 2023 → Jun 2024 | — | Cairo University | Completed | No outcome recorded |
| — | NCT05532215 | Mar → Oct 2023 | — | OZORI EBIOGBO STANLEY | Unknown | No outcome recorded |
| — | NCT05696574 | Jan → Jun 2023 | pregnancy disorder | Cairo University | Unknown | No outcome recorded |
| — | NCT06726278 | Aug 2022 → Jul 2024 | cervix disorder | Hayat Abad Medical Complex, Peshawar | Completed | No outcome recorded |
| — | NCT05862428 | Feb → Sep 2022 | — | Queen Savang Vadhana Memorial Hospital, Thailand | Completed | No outcome recorded |
| — | NCT05094375 | Nov 2021 → Mar 2023 | pregnancy disorder with abortive outcome | hany farouk | Unknown | No outcome recorded |
| — | NCT05103098 | Nov 2021 → Dec 2022 | pregnancy disorder with abortive outcome | hany farouk | Unknown | No outcome recorded |
| — | NCT05088707 | Nov 2021 → Dec 2022 | pregnancy disorder with abortive outcome | Aswan University Hospital | Unknown | No outcome recorded |
| — | NCT05088720 | Nov 2021 → Dec 2022 | pregnancy disorder with abortive outcome | Aswan University Hospital | Unknown | No outcome recorded |
| — | NCT05077540 | Nov 2021 → Oct 2023 | — | Aswan University Hospital | Unknown | No outcome recorded |
| — | NCT04932382 | Oct 2021 → Mar 2023 | — | Assiut University | Completed | No outcome recorded |
| — | NCT05083910 | Jul 2021 → Jan 2022 | — | Bezmialem Vakif University | Completed | Met primary |
| — | NCT04887493 | Jun → Nov 2021 | — | Ministry of Health, Bhutan | Unknown | No outcome recorded |
| — | NCT06009679 | Feb 2021 → Dec 2024 | — | Assuta Ashdod Hospital | Unknown | No outcome recorded |
| — | NCT05857059 | Oct 2019 → May 2024 | obesity disorder, pregnancy disorder | Unidade Local de Saúde de Coimbra, EPE | Unknown | No outcome recorded |
| — | NCT03600064 | Jul 2019 → Jul 2020 | uterine inflammatory disease | Assiut University | Completed | No outcome recorded |
| — | NCT03748147 | Dec 2018 → Jun 2020 | indomethacin embryofetopathy | University of Cincinnati | Unknown | No outcome recorded |
| — | NCT03710317 | Dec 2018 → May 2020 | — | Aswan University Hospital | Completed | No outcome recorded |
| — | NCT03638856 | Sep → Dec 2018 | chronic pain syndrome, female infertility | Department of Medical Services Ministry of Public Health of Thailand | Completed | No outcome recorded |
| — | NCT03863392 | Jun → Nov 2018 | — | Ain Shams University | Unknown | No outcome recorded |
| — | NCT03440866 | Mar 2018 → Dec 2021 | — | HaEmek Medical Center, Israel | Unknown | Missed primary |
| — | NCT03148561 | Jul 2017 → Jul 2019 | pregnancy disorder with abortive outcome | Assiut University | Completed | Met primary |
| — | NCT03518463 | Jun → Jul 2017 | pregnancy disorder | Mbarara University of Science and Technology | Completed | No outcome recorded |
| — | NCT03043014 | Jun 2017 → Mar 2019 | — | Assistance Publique Hopitaux De Marseille | Completed | Met primary |
| — | NCT03031353 | Jan 2017 → May 2018 | persistent tachypnoe of infancy, usual | Ain Shams University | Unknown | No outcome recorded |
| — | NCT02983591 | Nov 2016 → Dec 2017 | — | Makassed General Hospital | Completed | No outcome recorded |
| — | NCT03239327 | Jun 2016 → Jan 2018 | newborn respiratory distress syndrome | Assiut University | Unknown | No outcome recorded |
| — | NCT02707653 | Mar → Nov 2016 | pregnancy disorder with abortive outcome | Gynuity Health Projects | Completed | No outcome recorded |
| — | NCT02581761 | Nov 2015 → Nov 2017 | — | Sheba Medical Center | Unknown | No outcome recorded |
| — | NCT02279914 | Nov 2014 → Aug 2016 | — | Planned Parenthood of Greater New York | Completed | No outcome recorded |
| — | NCT02013960 | Jan → Dec 2014 | — | Rambam Health Care Campus | Unknown | No outcome recorded |
| — | NCT01818414 | Oct 2013 → Mar 2014 | — | University of Pittsburgh | Terminated | Missed primary |
| — | NCT01916681 | May 2013 → Jun 2015 | — | University of Pennsylvania | Completed | Met primary |
| — | NCT01762319 | Nov 2012 → Jun 2013 | — | Mahidol University | Unknown | No outcome recorded |
| — | NCT01713153 | Jun 2012 → Jan 2014 | — | Gynuity Health Projects | Completed | Missed primary |
| — | NCT02411916 | Mar 2012 → Feb 2019 | — | New York City Health and Hospitals Corporation | Completed | No outcome recorded |
| — | NCT01508143 | Jan → Sep 2012 | — | Hormozgan University of Medical Sciences | Completed | No outcome recorded |
| — | NCT01462422 | Dec 2011 → Mar 2014 | — | Gynuity Health Projects | Completed | No outcome recorded |
| — | NCT01475318 | Oct 2011 → Jun 2012 | — | The University of Hong Kong | Unknown | No outcome recorded |
| — | NCT01939457 | Sep 2011 → Aug 2012 | pregnancy disorder with abortive outcome | Gynuity Health Projects | Completed | No outcome recorded |
| — | NCT01422226 | Jul 2011 → Feb 2012 | — | University of Colorado, Denver | Terminated | No outcome recorded Stop: Enrollment |
| — | NCT01307111 | Feb 2011 → Feb 2013 | — | University of New Mexico | Completed | No outcome recorded |
| — | NCT01147497 | Jun 2010 → Sep 2011 | — | Emory University | Completed | No outcome recorded |
| — | NCT01070472 | Mar 2010 → Jun 2011 | — | University of Manitoba | Completed | No outcome recorded |
| — | NCT01080846 | Feb → Aug 2010 | — | Gynuity Health Projects | Completed | Met primary |
| — | NCT02398838 | Dec 2009 → Apr 2012 | — | Gynuity Health Projects | Completed | No outcome recorded |
| — | NCT01001897 | Oct 2009 → Jan 2011 | — | University of Arizona | Completed | Missed primary |
| — | NCT01139801 | Sep 2009 → Mar 2010 | — | Aultman Health Foundation | Completed | No outcome recorded |
| — | NCT01173003 | Jun 2009 → Dec 2011 | — | Gynuity Health Projects | Completed | No outcome recorded |
| — | NCT00969982 | Jun 2009 → Jun 2013 | — | Gynuity Health Projects | Completed | Met primary |
| — | NCT00886834 | Apr 2009 → Mar 2011 | — | University of Utah | Completed | Missed primary |
| — | NCT01689311 | Mar 2009 → Aug 2011 | — | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Completed | Met primary |
| — | NCT00835731 | Jan 2009 → Dec 2011 | cervix disorder | Planned Parenthood League of Massachusetts | Completed | Missed primary |
| — | NCT01033903 | Oct 2008 → Dec 2015 | habitual spontaneous abortion | Region Skane | Completed | Met primary |
| — | NCT01718314 | Mar 2008 → Dec 2009 | — | Dr. Sami Ulus Children's Hospital | Completed | No outcome recorded |
| — | NCT00797693 | Jan → May 2008 | pregnancy disorder with abortive outcome | Hawler Medical University | Completed | No outcome recorded |
| — | NCT00680394 | Jul 2007 → May 2008 | — | Gynuity Health Projects | Completed | Met primary |
| — | NCT00613366 | Jun 2007 → Apr 2010 | — | Oregon Health and Science University | Completed | No outcome recorded |
| — | NCT00468299 | Apr 2007 → Dec 2008 | pregnancy disorder with abortive outcome | Boston University | Terminated | No outcome recorded Stop: Enrollment |
| — | NCT00495560 | Jan → Jul 2007 | — | Boston University | Completed | No outcome recorded |
| — | NCT00386867 | Oct 2006 → Mar 2007 | — | Gynuity Health Projects | Completed | Met primary |
| — | NCT00386282 | Sep 2006 → Mar 2011 | — | Gynuity Health Projects | Completed | No outcome recorded |
| — | NCT00674232 | May 2006 → Oct 2007 | pregnancy disorder with abortive outcome | Gynuity Health Projects | Completed | No outcome recorded |
| — | NCT00116480 | Dec 2005 → Apr 2007 | — | Gynuity Health Projects | Completed | No outcome recorded |
| — | NCT00124540 | Aug 2005 → Sep 2007 | — | Gynuity Health Projects | Completed | Missed primary |
| — | NCT00116350 | Jul 2005 → Jan 2008 | — | Gynuity Health Projects | Completed | No outcome recorded |
| — | NCT00120237 | Jul 2005 → Jul 2008 | anemia | Gynuity Health Projects | Completed | No outcome recorded |
| — | NCT00097123 | Sep 2002 → Dec 2005 | pregnancy disorder | NICHD Global Network for Women's and Children's Health | Completed | Met primary |
| — | NCT00385229 | Sep 2002 → Dec 2003 | perinatal disease | St. Olavs Hospital | Completed | No outcome recorded |
| — | NCT01487278 | — | — | Gynuity Health Projects | Withdrawn | No outcome recorded |
| Comparator or background therapy228 trials | ||||||
| Phase 0 | NCT07109258 Comparator | May → Sep 2025 overdue | — | Cairo University | Recruiting | No outcome recorded |
| Phase 0 | NCT06207539 Background | Dec 2022 → Mar 2023 | — | Ain Shams Maternity Hospital | Completed | No outcome recorded |
| Phase 0 | NCT05342974 Background | Apr 2022 → Dec 2023 | — | University of Utah | Completed | No outcome recorded |
| Phase 0 | NCT05001061 Comparator | Aug → Oct 2021 | pregnancy disorder with abortive outcome | Cairo University | Unknown | No outcome recorded |
| Phase 0 | NCT04478942 Comparator | Oct 2020 → Jan 2025 | preterm premature rupture of the membranes | University of Wisconsin, Madison | Completed | No outcome recorded |
| Show all 228 trials opens the full record — a long page | ||||||
News releases announcing trial results or a regulatory action · 2
| Date | Issuer | Release |
|---|---|---|
| 2020-08-17 | Norgine | Regulatory Norgine B.V. completes important regulatory milestone for ANGUSTA® (misoprostol) in Europe for oral induction of labour norgine.com ↗
The procedure has been concluded by the Danish Regulatory Authority, the Reference Member State for the assessment. |
| 2019-07-03 | Zydus Lifesciences Limited | Regulatory Misoprostol Tablets zyduslife.com ↗
Zydus Cadila has received the final approval from the USFDA to market Misoprostol Tablets (US RLD – Cytotec®), 100 mcg and 200 mcg. |
All press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2020-08-17 | Norgine | Norgine B.V. completes important regulatory milestone for ANGUSTA® (misoprostol) in Europe for oral induction of labour norgine.com ↗ |
| 2019-07-03 | Zydus Lifesciences Limited | Misoprostol Tablets zyduslife.com ↗ |
Evidence & citations 18 cited values
Every value below carries the sentence it was read from. 452 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Misoprostol | “In Misoprostol group (n=111), 400 microgram misoprostol (2 tablets - Cytotec, Pfizer, G.D. Searle LLC) will be inserted intraoperative inside the uterus after delivery of the placenta” NCT06060327 ↗444“OBJECTIVE: To compare the efficacy and safety of a 200-microgram misoprostol vaginal insert with a 10-mg dinoprostone vaginal insert for reducing the time to vaginal delivery.” PMID 23857539 ↗ Aug 2013 “Misoprostol, a prostaglandin E1 analogue, is the most interesting alternative to Dinoprostone because of its effectiveness, low cost, and temperature stability.” NCT02036437 ↗ “A tablet of DA9601, Cytotec (200ug of Misoprostol), Acrofen (100mg of Aceclofenac) will be assigned randomly to the subjects for four weeks.” NCT01912066 ↗ “800 micrograms misoprostol vaginally followed by 400 micrograms oral misoprostol every 3 hours with a maximum of four oral doses.” PMID 24084539 ↗ Oct 2013 “Recent evidence however has shown that misoprostol is associated with better outcomes and merits evaluation in our environment.” NCT06343480 ↗ “misoprostol tablet (400 mg) was placed into uterine cavity at the fundus after delivery of the placenta and swabbing the cavity” NCT05083910 ↗ “the recommended use of mifepristone or misoprostol as cervical preparation for the abortions after 12 weeks” NCT01795599 ↗ “Letrozole 2.5 mg each 12 hours for 2 days followed by vaginal misoprostol 800 mcg for induction of abortion” NCT04590482 ↗ “The first regimen will include a 200 mg oral dose of mifepristone followed by 800 mcg buccal misoprostol.” NCT01387256 ↗ “Dose reservoir of 100 mcg of misoprostol in a hydrogel polymer vaginal insert within a retrieval system.” NCT00828711 ↗ |
| Known as | Angusta | “A Comparative, Open-label, Parallel Design, Bioavailability Study of Two Misoprostol Formulations (Angusta™ 25 µg Dispersible Tablets vs. Cytotec® 200 µg Tablets) Following...” NCT02516631 ↗2“Oral misoprostol (ANGUSTA®) 25 µg every 2 hours, 8 times (maximum dosage should not exceed 200µg).” NCT04949633 ↗ “Norgine (who make Angusta, a 25 µg oral misoprostol tablet).” PMID 34155622 ↗ Jun 2021 |
| Known as | Cytotec | “A Comparative, Open-label, Parallel Design, Bioavailability Study of Two Misoprostol Formulations (Angusta™ 25 µg Dispersible Tablets vs. Cytotec® 200 µg Tablets) Following...” NCT02516631 ↗17“In Misoprostol group (n=111), 400 microgram misoprostol (2 tablets - Cytotec, Pfizer, G.D. Searle LLC) will be inserted intraoperative inside the uterus after delivery of the placenta” NCT06060327 ↗ “Patients assigned to PO Misoprostol (Cytotec) 400 mg once, 2-4 hours prior to hysteroscopy” NCT02474433 ↗ “misoprostol (Cytotec tables; Searle,A Division of Monsanto.P.L.C, England )0.8mg orally” NCT00677755 ↗ “only vaginal Misoprostol 800mcg (4 tablets Cytotec 200mcg ) ) every 3 hours” NCT04981457 ↗ “Misoprostol (Cytotec) is used widely in Obstetrics and Gynecology” NCT06009679 ↗ “800 µg sublingual misoprostol (Cytotec Pfizer, New York, USA)” NCT05077540 ↗ “Misoprostol (Cytotec; GD Searle and Co., Chicago, IL)” NCT00426491 ↗ “Misoprostol ( Cytotec) 200 microgram a tablet” NCT00797693 ↗ “Misoprostol ( Cytotec) 200 microgram a tablet” NCT07697781 ↗ “Misoprostol ( Cytotec) 200 microgram a tablet” NCT07465016 ↗ |
| Known as | Cytotec (brand name) | “Cytotec (brand name)” NCT04768010 ↗ |
| Known as | Misodel | “vaginal slow release misoprostol (Misodel®)” NCT02918110 ↗ |
| Known as | Misoprostol (Cytotec) | “Misoprostol (Cytotec)” NCT01933360 ↗ |
| Known as | Misoprostol is also known as Cytotec | “Misoprostol is also known as Cytotec” NCT01916681 ↗ |
| Known as | Misoprostol Vaginal Insert | “Misoprostol Vaginal Insert (MVI 100)” NCT00528255 ↗ |
| Known as | Misotac | “In the misoprostol group (n = 183), sublingual misoprostol was given by putting two moistened tablets of misoprostol (400 µg) under the tongue and allowing them to dissolve...” NCT01466530 ↗11“Women will receive vaginally one tablet misoprostol 200 mcg(Misotac; Sigma Pharma, SAE, EGYPT) plus one tablet isosorbide mononitrate 40 mg(Effox 40 mg; Minapharm).” NCT03587077 ↗ “misoprostol (misotac® sigma pharmaceutical industries) 200 mcg vaginally applied ten and four hours prior to the second attempt of IUD insertion” NCT03790371 ↗ “Misoprostol group (M) received 2 rectal misoprostol tablets (800 μg) (Misotac; SIGMA Pharm, Cairo, Egypt) after the delivery of the baby.” NCT03556852 ↗ “women will receive misoprostol 100 mcg (Misotac, Sigma Pharmaceuticals, Egypt) vaginally applied every 6 hours till cervical dilatation.” NCT03584698 ↗ “1 vaginal tablet of misoprostol (200mcg) (Misotac®; Sigma Pharma, SAE, Egypt) inserted by the study nurse 3 hours before IUD insertion.” NCT04080336 ↗ “the women will be received two tablets of misoprostol 400 mcg vaginally before IUD removal (Misotac®; Sigma Pharma, SAE, Egypt).” NCT03600064 ↗ “800μg rectal misoprostol (Misotac®, SIGMA, Egypt) immediately after urinary catheterization and before skin incision” NCT04635007 ↗ “received misoprostol 800 µg (Misotac 200 µg tablets, SIGMA pharmaceutical) once dose vaginally” NCT03148561 ↗ “1 vaginal tablet of misoprostol (200 mcg) (Misotac®; Sigma Pharma, SAE, Egypt)” NCT04080349 ↗ “two intrauterine misoprostol tablets (Misotac® 200microgram, Sigma Ph., Egypt)” NCT06364098 ↗ |
| Known as | Misotac (Misoprostol) | “Misotac (Misoprostol)” NCT02036437 ↗ |
| Known as | Misotac 200 µg tablets | “received misoprostol 800 µg (Misotac 200 µg tablets, SIGMA pharmaceutical) once dose sublingually” NCT05088720 ↗ |
| Known as | MVI | “Women enrolled into the Phase III trial, EXPEDITE (clinical trial registration: NCT01127581), had labour induced with either a misoprostol or dinoprostone vaginal insert (MVI or DVI).” PMID 25758619 ↗ Mar 2015 |
| Known as | MVI 100 | “Misoprostol Vaginal Insert (MVI 100)” NCT00528255 ↗ |
| Known as | PGE1 | “misoprostol (PGE1) 200ug” NCT02738177 ↗ |
| Known as | Prostaglandin E2 | “Introduction: The study aimed to investigate the effectiveness of a single versus double dose of Prostaglandin E2 "Misoprostol, 400 microgram" during myomectomy for multiple...” NCT02154932 ↗ |
| Known as | Vagiprost | “Pregnant women had taken misoprostol (vagiprost vaginal tablet; Adwia Pharmaceutical Company) vaginally as 25 micro gram of misoprostol.” NCT04514770 ↗2“vaginal misoprostol 25 μg (Vagiprost) tablets with vaginal estradiol 150 ml cream will be applied for induction of laour” NCT05306405 ↗ “followed by intravaginal 25mcg of misoprostol (Vagiprost)” NCT03523754 ↗ |
| Modality | Other / unclassified | “misoprostol, an orally active prostaglandin” PMID 21130990 ↗ Dec 2010 |
| Route | Oral | “misoprostol administered orally during the third stage of labor” NCT00097123 ↗ |